How do you approach evaluation and management of arthralgia in a patient after CAR-T cell therapy?

Topics: Hematologic Malignancies • Pediatric Oncology • Medical Oncology • Immunotherapy • Rheumatology • CAR-T • Hematology • General Rheumatology

Answer from: at Academic Institution

This is a great question - part of cytokine release at syndrome includes joint pain. So my questions are: How far after? What was the reason for the CAR-T? These are vital questions to understand first. To that be said - the answers will determine if you give a one-and-done treatment or long-...

Comments

at UTMB
Thank you. That was helpful.

Related Questions